PVP-I Nasal Sprays and SARS-CoV-2 Nasopharyngeal Titers (for COVID-19)
NCT04347954
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
47
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
Povidone-Iodine 2%
DRUG:
Povidone-Iodine 0.5%
DRUG:
Isotonic saline 0.9%
Sponsor
Stanford University